ReviewVaccine2022

COVID-19 management landscape: A need for an affordable platform to manufacture safe and efficacious biotherapeutics and prophylactics for the developing countries.

Vyankatesh Pidiyar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.